Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy

被引：12

作者：

Bret, Caroline ^{[1
,2
,3
]}

Viziteu, Elena ^{[2
]}

Kassambara, Alboukadel ^{[1
,2
]}

Moreaux, Jerome ^{[1
,2
,3
]}

机构：

[1] CHU Montpellier, Dept Biol Hematol, F-34295 Montpellier 5, France

[2] CNRS, Inst Human Genet, UPR1142, F-34396 Montpellier, France

[3] Univ Montpellier I, UFR Med, Montpellier, France

来源：

EXPERT REVIEW OF HEMATOLOGY | 2016年 / 9卷 / 04期

关键词：

targeted treatment; Genetic; Acute myeloid Leukemia; Risk factors; Epigenetics; ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; CHROMOSOMAL TRANSLOCATION FORMATION; HEMATOPOIETIC STEM; MONOSOMAL KARYOTYPE; DNA-DAMAGE; MICROSATELLITE INSTABILITY; GEMTUZUMAB OZOGAMICIN; PROGNOSTIC-SIGNIFICANCE;

D O I：

10.1586/17474086.2016.1141673

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute myeloid leukemia (AML) is a heterogeneous disease at molecular level, in response to therapy and prognosis. The molecular landscape of AML is evolving with new technologies revealing complex panorama of genetic abnormalities where genomic instability and aberrations of epigenetic regulators play a key role in pathogenesis. The characterization of AML diversity has led to development of new personalized therapeutic strategies to improve outcome of the patients.

引用

页码：351 / 360

页数：10

共 166 条

[1] Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia [J].

Abdel-Wahab, Omar ;

Levine, Ross L. .

BLOOD, 2013, 121 (18) :3563-3572

[2] Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies [J].

Abdel-Wahab, Omar ;

Mullally, Ann ;

Hedvat, Cyrus ;

Garcia-Manero, Guillermo ;

Patel, Jay ;

Wadleigh, Martha ;

Malinge, Sebastien ;

Yao, JinJuan ;

Kilpivaara, Outi ;

Bhat, Rukhmi ;

Huberman, Kety ;

Thomas, Sabrena ;

Dolgalev, Igor ;

Heguy, Adriana ;

Paietta, Elisabeth ;

Le Beau, Michelle M. ;

Beran, Miloslav ;

Tallman, Martin S. ;

Ebert, Benjamin L. ;

Kantarjian, Hagop M. ;

Stone, Richard M. ;

Gilliland, D. Gary ;

Crispino, John D. ;

Levine, Ross L. .

BLOOD, 2009, 114 (01) :144-147

[3] Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair [J].

Alcalay, M ;

Meani, N ;

Gelmetti, V ;

Fantozzi, A ;

Fagioli, M ;

Orleth, A ;

Riganelli, D ;

Sebastiani, C ;

Cappelli, E ;

Casciari, C ;

Sciurpi, MT ;

Mariano, AR ;

Minardi, SP ;

Luzi, L ;

Muller, H ;

Di Fiore, PP ;

Frosina, G ;

Pelicci, PG .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (11) :1751-1761

[4] Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy [J].

Allan, JM ;

Smith, AG ;

Wheatley, K ;

Hills, RK ;

Travis, LB ;

Hill, DA ;

Swirsky, DM ;

Morgan, GJ ;

Wild, CP .

BLOOD, 2004, 104 (13) :3872-3877

[5] XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia [J].

Banescu, Claudia ;

Duicu, Carmen ;

Trifa, Adrian P. ;

Dobreanu, Minodora .

LEUKEMIA & LYMPHOMA, 2014, 55 (02) :365-370

[6] Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition [J].

Berti, Matteo ;

Chaudhuri, Arnab Ray ;

Thangavel, Saravanabhavan ;

Gomathinayagam, Shivasankari ;

Kenig, Sasa ;

Vujanovic, Marko ;

Odreman, Federico ;

Glatter, Timo ;

Graziano, Simona ;

Mendoza-Maldonado, Ramiro ;

Marino, Francesca ;

Lucic, Bojana ;

Biasin, Valentina ;

Gstaiger, Matthias ;

Aebersold, Ruedi ;

Sidorova, Julia M. ;

Monnat, Raymond J., Jr. ;

Lopes, Massimo ;

Vindigni, Alessandro .

NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2013, 20 (03) :347-354

[7] Functional Connection between Rad51 and PML in Homology-Directed Repair [J].

Boichuk, Sergei ;

Hu, Liang ;

Makielski, Kathleen ;

Pandolfi, Pier Paolo ;

Gjoerup, Ole V. .

PLOS ONE, 2011, 6 (10)

[8] Monosomal karyotype in acute myeloid leukemia:: A better indicator of poor prognosis than a complex karyotype [J].

Breems, Dimitri A. ;

Van Putten, Wim L. J. ;

De Greef, Georgine E. ;

Van Zelderen-Bhola, Shama L. ;

Gerssen-Schoorl, Klasien B. J. ;

Mellink, Clemens H. M. ;

Nieuwint, Aggie ;

Jotterand, Martine ;

Hagemeijer, Anne ;

Beverloo, H. Berna ;

Lowenberg, Bob .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) :4791-4797

[9]

Bross PF, 2001, CLIN CANCER RES, V7, P1490

[10] PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination [J].

Bryant, Helen E. ;

Petermann, Eva ;

Schultz, Niklas ;

Jemth, Ann-Sofie ;

Loseva, Olga ;

Issaeva, Natalia ;

Johansson, Fredrik ;

Fernandez, Serena ;

McGlynn, Peter ;

Helleday, Thomas .

EMBO JOURNAL, 2009, 28 (17) :2601-2615

← 1 2 3 4 5 6 7 8 9 10 →